United States Biotechnology & Medical Research

MapLight Therapeutics, Inc. (MPLT)

Track

Track

MapLight Therapeutics experienced significant insider trading activity recently, marked by substantial buying from Catalyst4, Inc. totaling over 65 million dollars. Conversely, executives and affiliates initiated multiple planned sales. These movements occurred amid a 70.9 percent stock price decline over ninety days, following an August earnings report that showed a modest 5.7 percent profit beat.
Ticker: MPLT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for MapLight Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Planned sale
Price
110.83
Quantity 589 -17.6%
Value US$4,739,780
2.7
Hanson Kristopher Officer Officer
Transaction date
Proposed sale
Price
122.10
Quantity 40,788
Value US$3,033,135
2.4
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
283.32
Quantity 46,437 +7.0%
Value US$349,702
2.7
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.54
Quantity 22,082 -9.8%
Value US$276,908
2.7
Lillie James Woodruff Officer Officer
Transaction date
Proposed sale
Price
13.02
Quantity 22,082
Value US$287,508
2.7
Lillie James Woodruff Officer Officer
Transaction date
Proposed sale
Price
13.02
Quantity 22,082
Value US$287,508
2.3
Novo Holdings A/S Former Affiliate
Transaction date
Proposed sale
Price
15.02
Quantity 1,600,000
Value US$24,032,000
2.4
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 1,000,000 +5.0%
Value US$13,000,000
2.4
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
12.63
Quantity 3,000 +0.0%
Value US$37,890
2.4
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
11.69
Quantity 65,137 +0.3%
Value US$761,393
2.4
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
10.74
Quantity 141,088 +0.7%
Value US$1,515,511
1.2
Cox Troy Non-Executive Director
Transaction date
Purchase
Price
9.52
Quantity 15,620 +inf%
Value US$148,702
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Planned sale
Price
38.39
Quantity 200 -0.1%
Value US$7,678
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Planned sale
Price
37.70
Quantity 14,140 -7.5%
Value US$533,078
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Planned sale
Price
37.05
Quantity 2,833 -1.5%
Value US$104,963
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Planned sale
Price
38.17
Quantity 900 -0.6%
Value US$34,353
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Planned sale
Price
37.61
Quantity 16,969 -10.5%
Value US$638,204
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Planned sale
Price
36.51
Quantity 600 -0.4%
Value US$21,906
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.90
Quantity 16,779 -1.3%
Value US$635,924
2.7
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.90
Quantity 2,077 -0.9%
Value US$78,718
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.90
Quantity 1,130 -0.8%
Value US$42,827
2.7
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.90
Quantity 3,656 -1.2%
Value US$138,562
2.4
ANATOL KREITZER Officer Officer
Transaction date
Proposed sale
Price
37.22
Quantity 17,173
Value US$639,179
2.4
JONATHAN GILLIS Officer Officer
Transaction date
Proposed sale
Price
37.22
Quantity 18,469
Value US$687,416
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
37.44
Quantity 1,592 -0.8%
Value US$59,604
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
36.66
Quantity 7,464 -3.7%
Value US$273,630
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
37.44
Quantity 1,476 -0.9%
Value US$55,261
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
36.66
Quantity 6,979 -4.1%
Value US$255,850
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.96
Quantity 92 -0.0%
Value US$3,492
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.26
Quantity 28,091 -2.2%
Value US$1,046,671
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.46
Quantity 40,899 -3.1%
Value US$1,491,178
2.7
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.96
Quantity 12 -0.0%
Value US$456
2.7
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.26
Quantity 3,526 -1.5%
Value US$131,379
2.7
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
36.45
Quantity 5,009 -2.1%
Value US$182,578
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.96
Quantity 11 -0.0%
Value US$418
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.26
Quantity 3,331 -2.2%
Value US$124,113
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
36.45
Quantity 4,776 -3.1%
Value US$174,085
2.7
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.96
Quantity 19 -0.0%
Value US$721
2.7
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.26
Quantity 5,865 -1.9%
Value US$218,530
2.7
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
36.46
Quantity 9,163 -2.9%
Value US$334,083
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
36.94
Quantity 4,510 -2.2%
Value US$166,599
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
36.13
Quantity 5,545 -2.6%
Value US$200,341
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
36.94
Quantity 4,699 -2.7%
Value US$173,581
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
36.13
Quantity 5,356 -3.0%
Value US$193,512
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.54
Quantity 90 -0.0%
Value US$3,379
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.99
Quantity 42,738 -3.1%
Value US$1,580,879
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.00
Quantity 18,950 -1.4%
Value US$682,200
2.7
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.54
Quantity 12 -0.0%
Value US$450
2.7
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
36.99
Quantity 5,393 -2.2%
Value US$199,487
2.7
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
36.00
Quantity 2,238 -0.9%
Value US$80,568
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.54
Quantity 10 -0.0%
Value US$375
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
36.99
Quantity 5,103 -3.2%
Value US$188,760
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
36.00
Quantity 2,147 -1.3%
Value US$77,292
2.7
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.54
Quantity 18 -0.0%
Value US$676
2.7
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
36.99
Quantity 8,972 -2.7%
Value US$331,874
2.7
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
36.00
Quantity 4,465 -1.3%
Value US$160,740
2.7
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Planned sale
Price
37.04
Quantity 7,845 -2.3%
Value US$290,579
2.7
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Planned sale
Price
36.16
Quantity 7,155 -2.1%
Value US$258,725
2.4
Anatol Kreitzer Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 36,284
Value US$1,375,526
2.4
Jonathan Gillis Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 36,979
Value US$1,401,874
2.4
Anatol Kreitzer Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 33,605
Value US$1,273,966
2.7
Foff Erin Pennock Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 48,158
Value US$1,825,670
1.4
ROBERT MALENKA Director Non-Executive Director
Transaction date
Proposed sale
Price
37.91
Quantity 17,537
Value US$664,828
2.7
Kroeger Christopher A. Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 152,230
Value US$5,771,039
2.7
Hanson Kristopher Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 16,508
Value US$625,818
2.7
Lillie James Woodruff Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 18,835
Value US$714,035
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.15
Quantity 198 -0.0%
Value US$5,574
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.19
Quantity 118,037 -7.8%
Value US$3,209,426
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
30.56
Quantity 5,890 -0.4%
Value US$179,998
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
30.04
Quantity 6,871 -0.5%
Value US$206,405
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.70
Quantity 877 -0.1%
Value US$25,170
2.7
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.57
Quantity 342 -0.0%
Value US$9,429
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Planned sale
Price
30.56
Quantity 5,808 -3.5%
Value US$177,492
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Planned sale
Price
30.04
Quantity 6,979 -4.0%
Value US$209,649
2.7
Hanson Kristopher General Counsel Officer
Transaction date
Planned sale
Price
28.70
Quantity 846 -0.5%
Value US$24,280
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-18 2026-09-16 PlS Planned sale
2.7
Hanson Kristopher

General Counsel

Officer
589 -17.6%
110.83
US$4,739,780 		589 -17.6% 110.83 US$4,739,780
2026-09-16 2026-09-16 PrS Proposed sale
2.7
Hanson Kristopher

Officer

Officer
40,788
122.10
US$3,033,135 		40,788 122.10 US$3,033,135
2026-08-18 2026-08-14 B Purchase
2.4
Catalyst4, Inc.
Large shareholder
46,437 +7.0%
283.32
US$349,702 		46,437 +7.0% 283.32 US$349,702
2026-08-04 2026-08-03 PlS Planned sale
2.7
Lillie James Woodruff

Chief Scientific Officer

Officer
22,082 -9.8%
12.54
US$276,908 		22,082 -9.8% 12.54 US$276,908
2026-08-03 2026-08-03 PrS Proposed sale
2.7
Lillie James Woodruff

Officer

Officer
22,082
13.02
US$287,508 		22,082 13.02 US$287,508
2026-08-03 2026-08-03 PrS Proposed sale
2.7
Lillie James Woodruff

Officer

Officer
22,082
13.02
US$287,508 		22,082 13.02 US$287,508
2026-07-30 2026-07-30 PrS Proposed sale
2.3
Novo Holdings A/S

Former Affiliate
1,600,000
15.02
US$24,032,000 		1,600,000 15.02 US$24,032,000
2026-07-30 2026-07-30 B Purchase
2.4
Catalyst4, Inc.
Large shareholder
1,000,000 +5.0%
13.00
US$13,000,000 		1,000,000 +5.0% 13.00 US$13,000,000
2026-07-30 2026-07-29 B Purchase
2.4
Catalyst4, Inc.
Large shareholder
3,000 +0.0%
12.63
US$37,890 		3,000 +0.0% 12.63 US$37,890
2026-07-30 2026-07-28 B Purchase
2.4
Catalyst4, Inc.
Large shareholder
65,137 +0.3%
11.69
US$761,393 		65,137 +0.3% 11.69 US$761,393
2026-07-30 2026-07-28 B Purchase
2.4
Catalyst4, Inc.
Large shareholder
141,088 +0.7%
10.74
US$1,515,511 		141,088 +0.7% 10.74 US$1,515,511
2026-07-28 2026-07-28 B Purchase
1.2
Cox Troy
Non-Executive Director
15,620 +inf%
9.52
US$148,702 		15,620 +inf% 9.52 US$148,702
2026-07-20 2026-07-17 PlS Planned sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
200 -0.1%
38.39
US$7,678 		200 -0.1% 38.39 US$7,678
2026-07-20 2026-07-17 PlS Planned sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
14,140 -7.5%
37.70
US$533,078 		14,140 -7.5% 37.70 US$533,078
2026-07-20 2026-07-17 PlS Planned sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
2,833 -1.5%
37.05
US$104,963 		2,833 -1.5% 37.05 US$104,963
2026-07-20 2026-07-17 PlS Planned sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
900 -0.6%
38.17
US$34,353 		900 -0.6% 38.17 US$34,353
2026-07-20 2026-07-17 PlS Planned sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
16,969 -10.5%
37.61
US$638,204 		16,969 -10.5% 37.61 US$638,204
2026-07-20 2026-07-17 PlS Planned sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
600 -0.4%
36.51
US$21,906 		600 -0.4% 36.51 US$21,906
2026-07-17 2026-07-17 S Sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
16,779 -1.3%
37.90
US$635,924 		16,779 -1.3% 37.90 US$635,924
2026-07-17 2026-07-17 S Sale
2.7
Lillie James Woodruff

Chief Scientific Officer

Officer
2,077 -0.9%
37.90
US$78,718 		2,077 -0.9% 37.90 US$78,718
2026-07-17 2026-07-17 S Sale
2.7
Hanson Kristopher

General Counsel

Officer
1,130 -0.8%
37.90
US$42,827 		1,130 -0.8% 37.90 US$42,827
2026-07-17 2026-07-17 S Sale
2.7
Foff Erin Pennock

Chief Medical Officer

Officer
3,656 -1.2%
37.90
US$138,562 		3,656 -1.2% 37.90 US$138,562
2026-07-17 2026-07-17 PrS Proposed sale
2.4
ANATOL KREITZER

Officer

Officer
17,173
37.22
US$639,179 		17,173 37.22 US$639,179
2026-07-17 2026-07-17 PrS Proposed sale
2.4
JONATHAN GILLIS

Officer

Officer
18,469
37.22
US$687,416 		18,469 37.22 US$687,416
2026-07-20 2026-07-16 S Sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
1,592 -0.8%
37.44
US$59,604 		1,592 -0.8% 37.44 US$59,604
2026-07-20 2026-07-16 S Sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
7,464 -3.7%
36.66
US$273,630 		7,464 -3.7% 36.66 US$273,630
2026-07-20 2026-07-16 S Sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
1,476 -0.9%
37.44
US$55,261 		1,476 -0.9% 37.44 US$55,261
2026-07-20 2026-07-16 S Sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
6,979 -4.1%
36.66
US$255,850 		6,979 -4.1% 36.66 US$255,850
2026-07-17 2026-07-16 S Sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
92 -0.0%
37.96
US$3,492 		92 -0.0% 37.96 US$3,492
2026-07-17 2026-07-16 S Sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
28,091 -2.2%
37.26
US$1,046,671 		28,091 -2.2% 37.26 US$1,046,671
2026-07-17 2026-07-16 S Sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
40,899 -3.1%
36.46
US$1,491,178 		40,899 -3.1% 36.46 US$1,491,178
2026-07-17 2026-07-16 S Sale
2.7
Lillie James Woodruff

Chief Scientific Officer

Officer
12 -0.0%
37.96
US$456 		12 -0.0% 37.96 US$456
2026-07-17 2026-07-16 S Sale
2.7
Lillie James Woodruff

Chief Scientific Officer

Officer
3,526 -1.5%
37.26
US$131,379 		3,526 -1.5% 37.26 US$131,379
2026-07-17 2026-07-16 S Sale
2.7
Lillie James Woodruff

Chief Scientific Officer

Officer
5,009 -2.1%
36.45
US$182,578 		5,009 -2.1% 36.45 US$182,578
2026-07-17 2026-07-16 S Sale
2.7
Hanson Kristopher

General Counsel

Officer
11 -0.0%
37.96
US$418 		11 -0.0% 37.96 US$418
2026-07-17 2026-07-16 S Sale
2.7
Hanson Kristopher

General Counsel

Officer
3,331 -2.2%
37.26
US$124,113 		3,331 -2.2% 37.26 US$124,113
2026-07-17 2026-07-16 S Sale
2.7
Hanson Kristopher

General Counsel

Officer
4,776 -3.1%
36.45
US$174,085 		4,776 -3.1% 36.45 US$174,085
2026-07-17 2026-07-16 S Sale
2.7
Foff Erin Pennock

Chief Medical Officer

Officer
19 -0.0%
37.96
US$721 		19 -0.0% 37.96 US$721
2026-07-17 2026-07-16 S Sale
2.7
Foff Erin Pennock

Chief Medical Officer

Officer
5,865 -1.9%
37.26
US$218,530 		5,865 -1.9% 37.26 US$218,530
2026-07-17 2026-07-16 S Sale
2.7
Foff Erin Pennock

Chief Medical Officer

Officer
9,163 -2.9%
36.46
US$334,083 		9,163 -2.9% 36.46 US$334,083
2026-07-20 2026-07-15 S Sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
4,510 -2.2%
36.94
US$166,599 		4,510 -2.2% 36.94 US$166,599
2026-07-20 2026-07-15 S Sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
5,545 -2.6%
36.13
US$200,341 		5,545 -2.6% 36.13 US$200,341
2026-07-20 2026-07-15 S Sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
4,699 -2.7%
36.94
US$173,581 		4,699 -2.7% 36.94 US$173,581
2026-07-20 2026-07-15 S Sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
5,356 -3.0%
36.13
US$193,512 		5,356 -3.0% 36.13 US$193,512
2026-07-17 2026-07-15 S Sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
90 -0.0%
37.54
US$3,379 		90 -0.0% 37.54 US$3,379
2026-07-17 2026-07-15 S Sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
42,738 -3.1%
36.99
US$1,580,879 		42,738 -3.1% 36.99 US$1,580,879
2026-07-17 2026-07-15 S Sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
18,950 -1.4%
36.00
US$682,200 		18,950 -1.4% 36.00 US$682,200
2026-07-17 2026-07-15 S Sale
2.7
Lillie James Woodruff

Chief Scientific Officer

Officer
12 -0.0%
37.54
US$450 		12 -0.0% 37.54 US$450
2026-07-17 2026-07-15 S Sale
2.7
Lillie James Woodruff

Chief Scientific Officer

Officer
5,393 -2.2%
36.99
US$199,487 		5,393 -2.2% 36.99 US$199,487
2026-07-17 2026-07-15 S Sale
2.7
Lillie James Woodruff

Chief Scientific Officer

Officer
2,238 -0.9%
36.00
US$80,568 		2,238 -0.9% 36.00 US$80,568
2026-07-17 2026-07-15 S Sale
2.7
Hanson Kristopher

General Counsel

Officer
10 -0.0%
37.54
US$375 		10 -0.0% 37.54 US$375
2026-07-17 2026-07-15 S Sale
2.7
Hanson Kristopher

General Counsel

Officer
5,103 -3.2%
36.99
US$188,760 		5,103 -3.2% 36.99 US$188,760
2026-07-17 2026-07-15 S Sale
2.7
Hanson Kristopher

General Counsel

Officer
2,147 -1.3%
36.00
US$77,292 		2,147 -1.3% 36.00 US$77,292
2026-07-17 2026-07-15 S Sale
2.7
Foff Erin Pennock

Chief Medical Officer

Officer
18 -0.0%
37.54
US$676 		18 -0.0% 37.54 US$676
2026-07-17 2026-07-15 S Sale
2.7
Foff Erin Pennock

Chief Medical Officer

Officer
8,972 -2.7%
36.99
US$331,874 		8,972 -2.7% 36.99 US$331,874
2026-07-17 2026-07-15 S Sale
2.7
Foff Erin Pennock

Chief Medical Officer

Officer
4,465 -1.3%
36.00
US$160,740 		4,465 -1.3% 36.00 US$160,740
2026-07-17 2026-07-15 PlS Planned sale
2.7
Foff Erin Pennock

Chief Medical Officer

Officer
7,845 -2.3%
37.04
US$290,579 		7,845 -2.3% 37.04 US$290,579
2026-07-17 2026-07-15 PlS Planned sale
2.7
Foff Erin Pennock

Chief Medical Officer

Officer
7,155 -2.1%
36.16
US$258,725 		7,155 -2.1% 36.16 US$258,725
2026-07-15 2026-07-15 PrS Proposed sale
2.4
Anatol Kreitzer

Officer

Officer
36,284
37.91
US$1,375,526 		36,284 37.91 US$1,375,526
2026-07-15 2026-07-15 PrS Proposed sale
2.4
Jonathan Gillis

Officer

Officer
36,979
37.91
US$1,401,874 		36,979 37.91 US$1,401,874
2026-07-15 2026-07-15 PrS Proposed sale
2.4
Anatol Kreitzer

Officer

Officer
33,605
37.91
US$1,273,966 		33,605 37.91 US$1,273,966
2026-07-15 2026-07-15 PrS Proposed sale
2.7
Foff Erin Pennock

Officer

Officer
48,158
37.91
US$1,825,670 		48,158 37.91 US$1,825,670
2026-07-15 2026-07-15 PrS Proposed sale
1.4
ROBERT MALENKA

Director

Non-Executive Director
17,537
37.91
US$664,828 		17,537 37.91 US$664,828
2026-07-15 2026-07-15 PrS Proposed sale
2.7
Kroeger Christopher A.

Officer

Officer
152,230
37.91
US$5,771,039 		152,230 37.91 US$5,771,039
2026-07-15 2026-07-15 PrS Proposed sale
2.7
Hanson Kristopher

Officer

Officer
16,508
37.91
US$625,818 		16,508 37.91 US$625,818
2026-07-15 2026-07-15 PrS Proposed sale
2.7
Lillie James Woodruff

Officer

Officer
18,835
37.91
US$714,035 		18,835 37.91 US$714,035
2026-05-18 2026-05-18 PlS Planned sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
198 -0.0%
28.15
US$5,574 		198 -0.0% 28.15 US$5,574
2026-05-18 2026-05-18 PlS Planned sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
118,037 -7.8%
27.19
US$3,209,426 		118,037 -7.8% 27.19 US$3,209,426
2026-05-11 2026-05-11 PlS Planned sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
5,890 -0.4%
30.56
US$179,998 		5,890 -0.4% 30.56 US$179,998
2026-05-11 2026-05-11 PlS Planned sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
6,871 -0.5%
30.04
US$206,405 		6,871 -0.5% 30.04 US$206,405
2026-05-11 2026-05-11 PlS Planned sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
877 -0.1%
28.70
US$25,170 		877 -0.1% 28.70 US$25,170
2026-05-11 2026-05-11 PlS Planned sale
2.7
Kroeger Christopher A.

Chief Executive Officer

Executive Director
342 -0.0%
27.57
US$9,429 		342 -0.0% 27.57 US$9,429
2026-05-11 2026-05-11 PlS Planned sale
2.7
Hanson Kristopher

General Counsel

Officer
5,808 -3.5%
30.56
US$177,492 		5,808 -3.5% 30.56 US$177,492
2026-05-11 2026-05-11 PlS Planned sale
2.7
Hanson Kristopher

General Counsel

Officer
6,979 -4.0%
30.04
US$209,649 		6,979 -4.0% 30.04 US$209,649
2026-05-11 2026-05-11 PlS Planned sale
2.7
Hanson Kristopher

General Counsel

Officer
846 -0.5%
28.70
US$24,280 		846 -0.5% 28.70 US$24,280
Explore more

More insider trading research around MapLight Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America